← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Cibots, Inc.
San Diego, CA
$1,242,726
Total funding
3
Grants
Funding over time
peak $479.7K · FY2017–24$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,242,726 · 3
By mechanism
R43$1,242,726 · 3
Investigators at Cibots, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Xylazine and opioid overdose mitigation therapy using decoy receptor biomimetic nanoparticles, NarcoBond platform$479,731
R43 · FY2024 · DA
NarcoBond: Opioid Targeted Biomimetic Nanosponges for Treatment of Opioid Overdose$254,039
R43 · FY2019 · DA
Direct Conversion of Human Fibroblasts into Neuronal Cells by Small Molecules (hCiN)$223,988
R43 · FY2017 · DA
Direct Conversion of Human Fibroblasts into Neuronal Cells by Small Molecules (hCiN)$139,068
R43 · FY2018 · DA
NarcoBond: Opioid Targeted Biomimetic Nanosponges for Treatment of Opioid Overdose$95,900
R43 · FY2020 · DA
Direct Conversion of Human Fibroblasts into Neuronal Cells by Small Molecules (hCiN)$50,000
R43 · FY2018 · DA